Annovis Bio (DE:07X)
FRANKFURT:07X
Holding DE:07X?
Track your performance easily

Annovis Bio (07X) Financial Statements

5 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Annovis Bio is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is €-0.47. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.02M$ -1.07M$ -14.86M$ -9.54M$ -9.74M
EBITDA$ -5.02M$ -1.07M$ -14.86M$ -9.54M$ -9.74M
Net Income Common Stockholders$ -5.02M$ -1.07M$ -14.72M$ -9.54M$ -9.74M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.00M$ 3.10M$ 6.35M$ 15.72M$ 16.76M
Total Assets$ 5.05M$ 7.78M$ 10.22M$ 22.82M$ 25.55M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.00M$ -3.10M$ -6.35M$ -15.72M$ -16.76M
Total Liabilities$ 6.80M$ 11.17M$ 3.56M$ 2.07M$ 5.41M
Stockholders Equity$ -1.75M$ -3.33M$ 6.66M$ 20.74M$ 20.14M
Cash Flow-
Free Cash Flow$ -3.38M$ -7.03M$ -9.37M$ -9.61M$ -11.63M
Operating Cash Flow$ -3.38M$ -7.03M$ -9.37M$ -9.61M$ -11.63M
Investing Cash Flow-----
Financing Cash Flow$ 4.24M$ 4.42M-$ 8.57M$ 7.39K
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis